Kyorin Pharmaceutical Co. Ltd.

Plus: Hummingbird/Callio, Bridgene/Takeda, Magnet/Lilly, Gensaic/Novo, and more

Academia remains the primary source of innovation, but industry spinouts rose in number last year

Three late-stage readouts this year and multiple mechanisms in the clinic could lift the lid on ALS treatments

Start-up obtains S1PR modulator from Kyorin

Led by Shire vets, the Austrian biotech is taking aim at a highly selective tumor antigen the biotech left behind

VCs led by MPM, Deerfield and Droia believe Frontier can reach previously undruggable targets through chemoproteomics

Why Scripps Research's non-profit model is doubling down on target discovery

Why methionine could have a place in the chemoproteomics toolbox